Rukiye Yasak Güner

Dr. Rukiye Yasak Güner


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2022 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
APA. Kara Polat
A. Kara Polat
EAE. Alpsoy
E. Alpsoy
GKG. Kalkan
G. Kalkan
SAS. Aytekin
S. Aytekin
DUD. Uçmak
D. Uçmak
AAA. Ataseven
A. Ataseven

8 July 2021 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
SSS. Sarıkaya Solak
S. Sarıkaya Solak
APA. Kara Polat
A. Kara Polat
SKS. Kilic
S. Kilic
ITİ. Oguz Topal
İ. Oguz Topal
HSH. Saricaoglu
H. Saricaoglu
EAE. Alpsoy
E. Alpsoy


26 April 2022 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
MTMUSTAFA TOSUN
MUSTAFA TOSUN
RGRukiye Yasak Güner
Rukiye Yasak Güner
MAMelih Akyol
Melih Akyol

22 May 2021 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
RGRukiye Yasak Güner
Rukiye Yasak Güner
MTMustafa Tosun
Mustafa Tosun
MAMelih Akyol
Melih Akyol
SHSibel Berksoy Hayta
Sibel Berksoy Hayta

11 May 2024 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
FEFunda Erduran
Funda Erduran
EAEsra Adışen
Esra Adışen
YHYıldız Hayran
Yıldız Hayran
GAGüneş Gür Aksoy
Güneş Gür Aksoy
EAErkan Alpsoy
Erkan Alpsoy
AAAkın Aktaş
Akın Aktaş
Pyoderma Gangrenosum (PG) is a chronic disease characterized by recalcitrant skin ulcers. We aimed to evaluate the demographic, clinical characteristics, treatments and factors affecting the treatment responses of patients with PG. We performed a multicenter study of 12 tertiary care centers. We analyzed the data of the patients who were followed up with a diagnosis of PG between the years 2012‒2022 retrospectively. We included a total of 239 patients of whom 143 were female and 96 were male, with an average age of 54.2 ± 17.4 years. The most common treatment was systemic steroids (n = 181, 75.7%). Among these patients, 50.8% (n = 92) used systemic steroids as the sole systemic agent, while 49.2% (n = 89) used at least one adjuvant immunosuppressive agent. The independent factors determined in regression analysis to influence response to systemic steroids positively were disease onset age ≥ 30-years, negative pathergy, absence of leukocytosis, negative wound culture, presence of a single lesion, and absence of upper extremity involvement. Biological agents were used in 18.4% (n = 44) of the patients in the present study. We also analyzed pathergy positive PG and early onset (onset age < 30) PG separately due to their distinct clinical features which were revealed during statistical analysis. Retrospective nature of the present study. Analyses of the factors influencing treatment responses are addressed in this study. Also, we concluded that investigation for accompanying autoinflammatory diseases of pathergy positive PG and early onset PG is necessary and the patients in these two groups are more resistant to treatment, necessitating more complicated treatments.